To investigate the effects of ST6GAL1-mediated sialylation on EGFR activity, we assessed EGFR activation in pancreatic, ovarian, and colon cancer cell lines in which ST6GAL1 expression was directly modulated. Here, EGFR is linked to colonic neoplasm.